Companies · Other Health Care

Tactile Systems Technology Inc

MINNEAPOLIS · Other Health Care

Diligence memoA one-page analyst read on Tactile Systems Technology Inc — recommendation, valuation, rhythm, risks.
$23.4M
Total raised · real
7
Rounds
1.1×
Latest step-up
Top 15%
Sector rank · raised
Series A
Latest stage · inferred · Fri Sep 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time)

Tactile Systems Technology Inc looks over-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Over-valued
  • Modeled value is 1.81× the median modeled value of Series A Other Health Care companies in 2010–2012 (199 peers) — value vs value, same stage and era.
Dormant
  • Last raise 13.8 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Tactile Systems Technology Inc is one of 5376 Other Health Care companies tracked from MINNEAPOLIS. By capital raised it ranks in the upper tier (ahead of 86% of sector peers), and in the upper tier by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$125M$250M$375M$500MPre-Seed · 2009-07-01 Raised $979K (real) Modeled valuation $30M (est)Pre-Seed2009Pre-Seed · 2009-07-01 Raised $715K (real) Modeled valuation $22M (est)Pre-Seed2009Pre-Seed · 2009-07-01 Raised $415K (real) Modeled valuation $13M (est)Pre-Seed2009Pre-Seed · 2009-07-01 Raised $1000K (real) Modeled valuation $31M (est)Pre-Seed2009Pre-Seed · 2009-07-01 Raised $821K (real) Modeled valuation $25M (est)Pre-Seed2009Series A · 2012-09-14 Raised $9.1M (real) Modeled valuation $184M (est)Series A2012Series A · 2012-09-14 Raised $10M (real) Modeled valuation $210M (est)Series A2012+$715K+$415K+$1000K+$821K+$9.1M+$10MCumulative $23M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Pre-Seed$979K · 2009
Pre-Seed extension$715K · 2009
Pre-Seed extension$415K · 2009
Pre-Seed extension$1000K · 2009
Pre-Seed extension$821K · 2009
Series A$9.1M · 2012no Seed on file
Series A extension$10.4M · 2012

Stages are modeled from round size (public records carry no series label). No record for: Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 67%.

Modeled valuation trajectory
$209.9M
Base estimate est.
$13.3M
Conservative case
$1.1B
Upside case
$47.3M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Aa $4.0M–$15M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Pre-Seed · modeled $30.2M · 2009-07-012009Pre-Seed · modeled $22.0M · 2009-07-01Pre-Seed · modeled $12.8M · 2009-07-01Pre-Seed · modeled $30.8M · 2009-07-01Pre-Seed · modeled $25.3M · 2009-07-01Series A · modeled $183.6M · 2012-09-14Series A · modeled $209.9M · 2012-09-142012
Model inputs · modeled:benchmark-stage-stepup-v1
22%
Dilution assumption
Implied ownership sold in the financing.
52%
Survival probability
28% low · 71% high
1.43×/yr
Annual markup
1.80×/yr upside case
6.0 yr
Elapsed time used
13.8 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
6 mo
Avg between rounds
$7.3M/yr
Capital velocity
17.0 yr
On record since
2009
First round
7
Rounds on file
How it compares to the market

Benchmarked against 5376 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 9.6× above median
This company$23.4M
Sector median$2.4M
Latest round — vs other Series A rounds in sector (real $, this stage) 1.9× above median
This company$10.4M
Sector median$5.6M
Modeled value — vs sector median (estimate, all stages) 9.5× above median
This company$209.9M
Sector median$22.1M

Raised more than 86% of sector peers (real $). Modeled value above 88% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series A) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #26 of 199.

This companyCohort peer
$100.0M$1.0B$10.0M$100.0MCapital raised (log)Barrx Medical Inc · Series A Raised $15.0M · modeled $302.7M (est)Cas Medical Systems Inc · Series A Raised $16.9M · modeled $302.7M (est)Icad Inc · Series A Raised $27.1M · modeled $302.7M (est)Cardiosolutions Inc · Series A Raised $18.5M · modeled $300.3M (est)Ophthonix Inc · Series A Raised $24.7M · modeled $283.4M (est)FMS Watertown, LLC · Series A Raised $13.7M · modeled $277.2M (est)Flowood Vascular Access, LLC · Series A Raised $13.7M · modeled $277.2M (est)Cardiovascular Systems Inc · Series A Raised $58.5M · modeled $272.4M (est)HemaSource Holdings LLC · Series A Raised $13.5M · modeled $272.2M (est)OMNI Home Health Acquisition, LLC · Series A Raised $12.6M · modeled $253.2M (est)Integrated Sleep Holdings Inc · Series A Raised $12.4M · modeled $249.9M (est)AngioScore Inc. · Series A Raised $12.0M · modeled $242.2M (est)Tactile Systems Technology Inc (this company) Raised $23.4M · modeled $209.9M (est)Tactile Systems Technology Inc
CompanyStageRaised · realValue · estvs peer med.
Barrx Medical IncSeries A$15.0M$302.7M2.60×
Cas Medical Systems IncSeries A$16.9M$302.7M2.60×
Icad IncSeries A$27.1M$302.7M2.60×
Cardiosolutions IncSeries A$18.5M$300.3M2.58×
Ophthonix IncSeries A$24.7M$283.4M2.44×
FMS Watertown, LLCSeries A$13.7M$277.2M2.38×
Flowood Vascular Access, LLCSeries A$13.7M$277.2M2.38×
Cardiovascular Systems IncSeries A$58.5M$272.4M2.34×
HemaSource Holdings LLCSeries A$13.5M$272.2M2.34×
OMNI Home Health Acquisition, LLCSeries A$12.6M$253.2M2.18×
Integrated Sleep Holdings IncSeries A$12.4M$249.9M2.15×
AngioScore Inc.Series A$12.0M$242.2M2.08×
Tactile Systems Technology Inc this companySeries A$23.4M$209.9M1.81×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Pre-Seed$979K2009-07-01$5.4M$30.2M90%
Pre-Seed$715K2009-07-01$4.0M$22.0M90%
Pre-Seed$415K2009-07-01$2.3M$12.8M90%
Pre-Seed$1000K2009-07-01$5.6M$30.8M90%
Pre-Seed$821K2009-07-01$4.6M$25.3M90%
Series A$9.1M2012-09-14$41.4M$183.6M90%
Series A$10.4M2012-09-14$47.3M$209.9M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Pre-Seed$979K2009-07-01
    • First recorded raise — entered as Pre-Seed.
  2. Pre-Seed$715K2009-07-01
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.4× smaller than the prior — bridge or down round.
  3. Pre-Seed$415K2009-07-01
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.7× smaller than the prior — bridge or down round.
  4. Pre-Seed$1000K2009-07-01
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 2.4× larger than the prior — scaling up.
  5. Pre-Seed$821K2009-07-01
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
  6. Series A$9.1M2012-09-14
    • Raised again after 38 mo — slower than the ~14 mo sector norm.
    • Round 11.1× larger than the prior — scaling up.
  7. Series A$10.4M2012-09-14
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
Intelligence
2013 ~Q1
Modeled next raise · ~6mo cadence
$11.9M
Modeled next size est.range $10.4M$19.0M
1.1×
Last step-up
$7.3M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Kevin Roche5 other2009-07
Stephen Shapiro5 other2012-09
Doug Johnson4 other2009-07
Zubeen Shroff4 other2009-07
Gerald Mattys2 other2009-07
Jordan Davis2 other2012-09
Richard Nigon2 other2012-09
Irene Waldridge1 other2009-07
Mary Anderson1 other2009-07
Robert J. Folkes1 other2009-07
Andrew Isaacson2009-07
Bryan J. Rishe2009-07
Bryan Rishe2009-07
Dan Janisch2009-07
Mary J. Anderson2009-07
Mary Thompson2012-09
Peter Soderberg2012-09
Robert Folkes2009-07
Registry & provenance

Tactile Systems Technology Inc is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1027838
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Cambrooke Foods, Inc.Other Health CareSeries A$18.0M$202.3Mnetwork2 shared operators · same sector · same stage
Emerging Therapy Solutions, Inc.Other Health CareSeries A$24.3M$26.8Mnetwork1 shared operator · same sector · same stage
Augustine Temperature Management LLCOther Health CareSeries A$20.1M$201.8Mnetwork1 shared operator · same sector · same stage
Aperio Technologies IncOther Health CareSeries A$16.3M$117.4Mnetwork1 shared operator · same sector · same stage
PolyRemedy IncOther Health CareSeries A$13.7M$10.9Mnetwork1 shared operator · same sector · same stage
Pursuit Vascular, Inc.Other Health CareSeries A$12.3M$42.1Mnetwork1 shared operator · same sector · same stage
HCPlexus, Inc.Other Health CareSeries A$10.0M$201.8Mnetwork1 shared operator · same sector · same stage
NightWare, IncOther Health CareSeed$2.5M$546Knetwork2 shared operators · same sector
Frequently asked
How much funding has Tactile Systems Technology Inc raised?
Tactile Systems Technology Inc has raised approximately $23.4M in disclosed capital across 7 recorded financing rounds, aggregated from public filings.
What is Tactile Systems Technology Inc's estimated valuation?
Provath's modeled valuation for Tactile Systems Technology Inc is approximately $209.9M (modeled range $13.3M–$1.1B). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Tactile Systems Technology Inc at?
Tactile Systems Technology Inc's latest modeled financing stage is Series A. Its most recent recorded round closed around Fri Sep 14.
What does Tactile Systems Technology Inc do and where is it based?
Tactile Systems Technology Inc operates in the Other Health Care sector, based in MINNEAPOLIS.
Explore related

See where Tactile Systems Technology Inc sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Tactile Systems Technology Inc, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.